Similar to DLBCL and STAD, patients with THYM demonstrated higher levels of PSMD3 mRNA expression compared with normal controls, despite lower levels correlating with worse outcomes (Figure S2C). Here, PSMD3 is linked to diffuse large B-cell lymphoma.